PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
1-Year Return
49.19%
This Quarter Return
+16.29%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$106M
AUM Growth
+$11.3M
(+12%)
Cap. Flow
+$2.35M
Cap. Flow
% of AUM
2.22%
Top 10 Holdings %
Top 10 Hldgs %
34.45%
Holding
105
New
5
Increased
22
Reduced
41
Closed
8
Top Buys
| 1 |
MDxHealth
MDXH
|
$1.05M |
| 2 |
AKTS
AKOUSTIS TECHNOLOGIES, INC.
AKTS
|
$1.03M |
| 3 |
EMKR
Emcore Corp
EMKR
|
$961K |
| 4 |
Tactile Systems Technology
TCMD
|
$854K |
| 5 |
BIOL
Biolase, Inc.
BIOL
|
$753K |
Top Sells
| 1 |
Digi International
DGII
|
$1.31M |
| 2 |
Achieve Life Sciences
ACHV
|
$550K |
| 3 |
Perion Network
PERI
|
$332K |
| 4 |
ASPU
ASPEN GROUP, INC.
ASPU
|
$302K |
| 5 |
Quest Diagnostics
DGX
|
$231K |
Sector Composition
| 1 | Healthcare | 57.42% |
| 2 | Technology | 23.11% |
| 3 | Communication Services | 7.64% |
| 4 | Industrials | 5.85% |
| 5 | Consumer Staples | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cantaloupe
CTLP
$792M
| $1.56M | 1.47% |
274,350
-1,000
| -0.4% | -$5.7K |
|
27
OptimizeRx
OPRX
$349M
| $1.49M | 1.4% |
101,863
+100
| +0.1% | +$1.46K |
|
|
28
Tactile Systems Technology
TCMD
$300M
| $1.38M | 1.3% |
84,234
+52,000
| +161% | +$854K |
|
29
AtriCure
ATRC
$1.76B
| $1.38M | 1.3% |
33,350
| – | – |
|
30
QuickLogic
QUIK
$84.4M
| $1.38M | 1.3% |
232,463
-5,072
| -2% | -$30.1K |
|
|
31
MDxHealth
MDXH
$175M
| $1.32M | 1.25% |
408,725
+323,920
| +382% | +$1.05M |
|
32
Merck
MRK
$212B
| $1.26M | 1.19% |
11,825
-100
| -0.8% | -$10.6K |
|
33
Target
TGT
$42.3B
| $1.24M | 1.17% |
7,475
| – | – |
|
34
Magnite
MGNI
$3.54B
| $1.24M | 1.16% |
133,325
-2,750
| -2% | -$25.5K |
|
35
Fortress Biotech
FBIO
$110M
| $1.16M | 1.1% |
94,601
+39,767
| +73% | +$489K |
|
36
Gilead Sciences
GILD
$143B
| $1.13M | 1.07% |
13,617
-200
| -1% | -$16.6K |
|
37
FlexShopper
FPAY
$18.3M
| $1.1M | 1.04% |
1,296,960
+15,500
| +1% | +$13.2K |
|
38
Bristol-Myers Squibb
BMY
$96B
| $1.08M | 1.02% |
15,641
| – | – |
|
39
Vericel Corp
VCEL
$1.72B
| $993K | 0.94% |
33,867
-2,200
| -6% | -$64.5K |
|
|
EMKR
40
DELISTED
Emcore Corp
EMKR
| $961K | 0.91% |
+83,600
| New | +$961K |
|
41
Ciena
CIEN
$16.5B
| $945K | 0.89% |
18,000
| – | – |
|
|
42
Achieve Life Sciences
ACHV
$145M
| $933K | 0.88% |
137,212
-80,888
| -37% | -$550K |
|
|
PDCO
43
DELISTED
Patterson Companies, Inc.
PDCO
| $909K | 0.86% |
33,970
-1,800
| -5% | -$48.2K |
|
44
8x8 Inc
EGHT
$282M
| $882K | 0.83% |
211,500
+3,000
| +1% | +$12.5K |
|
45
Apple
AAPL
$3.56T
| $767K | 0.72% |
4,650
| – | – |
|
|
BIOL
46
DELISTED
Biolase, Inc.
BIOL
| $766K | 0.72% |
27,235
+26,773
| +5,795% | +$753K |
|
47
AT&T
T
$212B
| $752K | 0.71% |
39,042
-200
| -0.5% | -$3.85K |
|
48
Castle Biosciences
CSTL
$683M
| $707K | 0.67% |
31,110
| – | – |
|
49
BioLife Solutions
BLFS
$1.27B
| $696K | 0.66% |
32,000
| – | – |
|
50
Apyx Medical
APYX
$74.1M
| $647K | 0.61% |
224,800
+189,000
| +528% | +$544K |
|